Stock Market Articles

Private sector hiring in July added 44,000 jobs, falling short of economist expectations of 75,000 and marking the weakest month since January, complicating the Federal Reserve’s policy outlook.

Corn futures extended losses into Wednesday, declining 4 to 4.5 cents as crude oil weakness and long liquidation pressured prices. Cash corn fell to $4.13½, down 7¼ cents.

Wheat futures posted gains Wednesday morning after declining Tuesday across all three markets, with Chicago SRW contracts falling 11-14 cents and open interest rising nearly 2,000 contracts.

U.S. sustainable funds recorded positive inflows of nearly $3 billion in the second quarter, marking the first gain after fourteen consecutive quarters of net outflows since 2022.

Kyndryl shares declined in pre-market trading after reporting first-quarter fiscal 2027 results that missed both earnings and revenue expectations, though management reaffirmed full-year guidance.

Novo Nordisk shares fell about 6% after the Danish drugmaker released 2026 guidance that narrowed its sales and profit decline expectations but still disappointed investors.

Certara pivoted to a specialist sales model and divested its regulatory business, with software now representing 53% of revenue. The company reaffirmed full-year guidance of 0% to 4% growth while expanding margins.

Wayfair reported Q2 2026 revenue growth of 7.5% driven by a 6% increase in orders, marking the best sequential Q2 growth since 2020, while the luxury Perigold segment grew over 35%.

Westlake Chemical Partners reported stable net income of $14 million in Q2 2026, with distributable cash flow rising $3 million year-over-year amid steady operational performance and renewed financing agreements.

Revvity reported Q2 2026 earnings beat driven by strong pharma and biotech spending, with rising demand for AI-driven drug discovery platforms and raised full-year organic growth guidance to 4-5%.

Stevanato Group reported 8% revenue growth in the second quarter, driven by a 9% increase in its biopharmaceutical segment and strong high-value solutions performance, with full-year guidance adjusted to EUR 1.260-1.280 billion.

Chinese optical module makers’ shares tumbled after reports of a planned US import ban on new Chinese data centre components on national security grounds.